comparison of one result from a subject with the unstratified generally applicable reference interval will be a good guide to disease, since an unusual value for a subject will likely lie outside the reference limits and so be picked up by the clinician and simple computer flagging systems.
We do not consider that Gunn's analogy provides objective information to refute our suggestion. In comparing serum creatinine and creatinine clearance, we are investigating two alternatives for diagnosis of one condition, that is, renal impairment. Comparing calcium and PTH for the diagnosis of hyperparathyroidism is an interesting example. Gunn suggests that the study of Nussbaum et al. 4 shows large overlap of PTH results between patients with and without hyperparathyroidism. In fact, it is easy to calculate that the sensitivity is 95% when the specificity is 100 0 1. , and the specificity is 86% when the sensitivity is 100%; thus there is only small overlap between healthy subjects and patients with hyperparathyroidism. Would that all tests in our repertoire possessed these nosological performance characteristics. In addition, to quote from the publication, 'assay results for 37 individuals with surgically proven hyperparathyroidism were completely resolved from those for 24 patients with hypercalcaemia of malignancy'. Moreover, PTH was not compared with calcium as a criterion for diagnosis: all of the patients studied had hypercalcaemia. Furthermore, it should be noted that the data on intra-and inter-individual variation of PTH were obtained by Gunn and co-workers/ on only two specimens taken one week apart. In addition, unstratified serum creatinine and creatinine clearance corrected for surface area have very different indices of individuality (0'29 and 1,10, repsectively). In contrast, the indices for PTH and calcium are very similar, as far as can be deduced from the data quoted by Gunn." ELIZABETH 
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tance people show in giving blood for investigation studies, particularly in developing countries, and its potential as a vector for hepatitis and AIDS. On several occasions (e.g. Bourdoux et al. 2 ) , we have advocated the measurement of thiocyanate in urines rather than serum or plasma. Indeed, in Zaire we observed very high thiocyanate levels resulting from massive consumption of poorly detoxified cassava. These studies showed that thiocyanate levels in serum paralleled that in urine up to about 175~mol/L but above this threshold value, serum thiocyanate plateaued while urinary thiocyanate still increased.
The authors present an apparently new technique for measuring plasma thiocyanate although this technique is similar to the one originally proposed by Asmus and Garschagen (Fresenius' Z Anal Chern 1953; 138: 414) .
They discuss interfering compounds present 'mainly in the urine'. Do they have any information on the amount of such compounds in serum and urine respectively? They do not provide any information regarding the real extent of such interference in serum measurements and possibly on the nature of these compounds? Paradoxically, they justify the development of the proposed technique because of the poor specificity of other methods. If their technique is not restricted to thiocyanate alone, this should be clearly stated.
Finally, the assessment of the proposed technique rests on the comparison of eight samples with a technique they have previously reported! P BOURDOUX Saint Pierre University Hospital, Department of Radiosotopes, Rue Haute 322, B-1000 Brussels, Belgium
